Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center

 

See Also:

Learn More About Brent Rexer's Specialties:

VICC toll-free number 1-877-936-8422

Brent  Rexer

Brent Rexer, M.D., Ph.D.

Assistant Professor of Medicine (Hematology/Oncology)
Medical Oncologist

  • Appointments
    615-322-2064
    Physicians: 1-877-936-8422
  • Clinical Trials Information
  • Other Telephone Numbers
    Vanderbilt Breast Center at One Hundred Oaks
    615-322-2064

    Office
    615-322-4967
  • Faxes
    Vanderbilt Breast Center at One Hundred Oaks Fax
    615-343-3343
    Office Fax
    615-343-7602
    Clinic Fax
    615-343-3212
  • Addresses
    Clinic
    Vanderbilt Health One Hundred Oaks
    719 Thompson Ln
    Ste 25000
    Nashville, TN 37204

    Vanderbilt Breast Center at One Hundred Oaks
    719 Thompson Lane, Suite 25000
    Nashville, TN 37204
    Website

    Office
    2220 Pierce Ave.
    777 Preston Research Building
    Nashville, TN 37232-6307
Profile

Dr. Rexer is an Assistant Professor of Medicine in the Division of Hematology/Oncology.  He completed residency and fellowship training at Vanderbilt University Medical Center, after attending medical school at Vanderbilt and earning a Ph.D. in Biochemistry.  His research aims to understand mechanisms of resistance to targeted therapies in cancer and identify potential therapies to overcome that resistance.  In particular, he is focused on studying therapeutic resistance to lapatinib, a tyrosine kinase inhibitor of HER2, in breast cancer.  Dr.
Read more ....

Dr. Rexer is an Assistant Professor of Medicine in the Division of Hematology/Oncology.  He completed residency and fellowship training at Vanderbilt University Medical Center, after attending medical school at Vanderbilt and earning a Ph.D. in Biochemistry.  His research aims to understand mechanisms of resistance to targeted therapies in cancer and identify potential therapies to overcome that resistance.  In particular, he is focused on studying therapeutic resistance to lapatinib, a tyrosine kinase inhibitor of HER2, in breast cancer.  Dr. Rexer is an active member of the American Society of Clinical Oncology and the American Association for Cancer Research.

Education
  • Baylor University, B.S., Chemistry, 1994
  • Vanderbilt University, Ph.D., Biochemistry, 2001
  • Vanderbilt University School of Medicine, M.D., 2003
  • Internship and Residency, Internal Medicine, Vanderbilt University School of Medicine, 2005
  • Fellowship in Hematology/Oncology, Vanderbilt University School of Medicine, 2009